ADIPOQ and metabolic dysfunction-associated steatotic liver disease: In the current study, adiponectin serum level was significantly lower in NAFLD patients than in normal participants (P Value = 0.004); and also its level was lower in NASH patients in comparison to patients with simple steatosis.